Journal of Immunology Research 2021

2 papers

Top Research Directions

The 1 research directions with Journal of Immunology Research 2021 papers, ranked by paper count, next to 2020. Share is the fraction of the edition’s papers in the direction.

#Direction20212020Share 2021Share 20202020 rank
1Validating Novel Molecular Targets for Clinical Success1050.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Immunology Research 2021 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 2 credited papers.

#InstitutionPapersShare20202020 rank
101ty4bg86 150.0%0—
2Capital Medical University 150.0%0—
3China Medical University 150.0%0—
4Lund University 150.0%0—
5Shanghai Jiao Tong University 150.0%0—
6Sina (China) 150.0%12
7Skåne University Hospital 150.0%0—
8Yangzhou University 150.0%0—

Download all institutions as CSV

About this data

Papers. Journal of Immunology Research 2021 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2020 use shares, since the edition went from 2 to 2 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 2 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Immunology Research 2021”, https://lacuna.tiptreesystems.com/venue/journal-of-immunology-research/2021.

Papers

Title
Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression
Increased Nuclear Transporter KPNA2 Contributes to Tumor Immune Evasion by Enhancing PD-L1 Expression in PDAC